Syndeio Biosciences

News

Our round-up of recent biotech financings includes rounds for GRIN Therapeutics, GlycoEra, Syndeio, Juvenescence, and Vima Therapeutics.

News

The FDA has handed ImmunityBio a key label extension for bladder cancer therapy Anktiva, giving it a leg-up on rival drug Inlexzo from J&J.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.